Recently, Guangzhou Enzyme Products Biotechnology Co., Ltd. announced some exciting news – three of the company’s core technological achievements passed the expert review of the National Industrial Information Security Development Research Center and were awarded the “Science and Technology Achievement Registration Certificate” by the Ministry of Industry and Information Technology ! These three achievements focus on the integration and innovation of synthetic biology and active raw materials , fully demonstrating Enzyme Products’ exploration strength and industrialization capabilities in cutting-edge technology fields, and highlighting the company’s technical strength in green biomanufacturing and active materials.
The finished enzyme product relies on the self-developed artificial intelligence platform ReAI4Bio, which deeply integrates AI algorithms with genetic engineering, enzyme engineering, and strain engineering to construct an “AI-driven intelligent biomanufacturing system .” This system enables intelligent processing of the entire chain from gene design to product production , significantly improving the thermal stability, catalytic activity, and substrate tolerance of industrial enzymes—reducing enzyme modification that previously took years to complete to just a few months ! Currently, this technology has been successfully applied to S-Bosoxonine, NAD⁺, and NMN.The large-scale production of active ingredients such as carnosine has been achieved. The expert committee unanimously agreed that “the technology of this achievement has reached the international advanced level and has significant economic and social benefits.”
The enzyme product has independently built a collaborative “biology-enzyme-chemistry” platform, integrating gene editing, AI deep learning, and protein structure prediction to achieve intelligent modification, cleavage, and assembly of enzyme elements for peptides. This technology system has successfully overcome industry challenges such as the insertion of non-natural amino acids and precise assembly , achieving an assembly purity of up to 99.9% for complex peptides ! Currently, 21 invention patents have been applied for, with 5 already granted. Its applications are widely used in peptide drugs, functional skincare, and nutritional health , contributing to the development of the peptide industry.To achieve the leap from “following” to “leading”.
The enzyme product utilizes an independently developed integrated technology for peptide chemical synthesis and biomanufacturing , combining chemical synthesis, fermentation, and enzymatic methods to construct a highly efficient, low-cost, and scalable production system. This technology has been successfully applied to carnosine, glutathione, conostopeptide, and smegglutinin.These high-value raw materials are widely used in fields such as biomedicine, functional skincare, and nutrition and health . The expert panel commented: “This achievement has reached a leading level in China, with significant economic and social benefits.”
The company consistently prioritizes technological innovation as its core driving force, ranking among the top in its industry in terms of both the scale and intensity of R&D investment. Over 40% of its team members are involved in R&D, including scientists, professors, doctoral supervisors, chief engineers, and high-level national and local talents from globally renowned pharmaceutical companies, universities, and research institutions. The company has applied for over 230 invention patents, with 60 granted . The company has been recognized as a National Key Small Giant Enterprise for Specialized, Refined, and Innovative Technologies, a Guangdong Provincial Engineering Technology Center, a Guangdong Provincial and Shenzhen Municipal Postdoctoral Innovation Practice Base, and a Shenzhen Overseas High-Level Talent Team , among other accolades. It has also undertaken numerous key provincial and municipal science and technology R&D projects.
It’s worth mentioning that Enzyme is one of the earliest synthetic biology companies in China to introduce artificial intelligence into the field of enzyme engineering . As early as 2020, the company established an AI R&D team in the UK to conduct research on AI-assisted enzyme design and modification. In recent years, the company has focused on the three core elements of AI—algorithms, computing power, and data systems—building the ReAI4Bi0 platform, establishing its own computing center and database, and applying for nearly 30 AI-related invention patents.
After eight years of continuous investment, Enzyme Products has established a complete multidisciplinary biomanufacturing platform, possessing artificial intelligence, microbial synthesis, enzyme catalysis, and chemical synthesis technologies and mass production capabilities . This supports the company’s diversified product portfolio, achieves technological synergy and efficiency leaps, and provides a new paradigm for the future upgrading of the biomanufacturing industry. Enzyme Products will continue to uphold its mission of “Green Technology for a Healthy Life” and adhere to its strategic positioning as a “Leader of Green Active Raw Materials,” continuously promoting the deep integration of synthetic biology and artificial intelligence, accelerating the transformation of innovative achievements, and contributing to the high-quality development of China’s biomanufacturing industry.